524156 TCMLMTD

TCM Share Price

 

 

Start SIP in TCMLMTD

Start SIP

Performance

  • Low
  • ₹62
  • High
  • ₹68
  • 52 Week Low
  • ₹35
  • 52 Week High
  • ₹68
  • Open Price₹64
  • Previous Close₹63
  • Volume16,842

Investment Returns

  • Over 1 Month + 49.84%
  • Over 3 Month + 73.42%
  • Over 6 Month + 50.77%
  • Over 1 Year + 29.47%

Smart Investing Starts Here Start SIP with TCM for Steady Growth!

Invest Now

TCM Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 347
  • PEG Ratio
  • 3.1
  • Market Cap Cr
  • 49
  • P/B Ratio
  • 1.8
  • Average True Range
  • 4.31
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 4.18
  • RSI
  • 65.88
  • MFI
  • 77.32

TCM Financials

TCM Technicals

EMA & SMA

Current Price
₹65.90
+ 2.97 (4.72%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹56.82
  • 50 Day
  • ₹50.74
  • 100 Day
  • ₹47.03
  • 200 Day
  • ₹45.39

Resistance and Support

64.59 Pivot Speed
  • R3 72.28
  • R2 69.89
  • R1 66.98
  • S1 61.68
  • S2 59.29
  • S3 56.38

TCM Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-11 Quarterly Results
2025-08-11 Quarterly Results
2025-05-29 Audited Results
2025-02-10 Quarterly Results & Others To consider other business matters. issue of equity shares of Rs. 10/- each in the ratio of 6:5 @ premium of Rs. 15/-.
2024-11-12 Quarterly Results

TCM F&O

TCM Shareholding Pattern

49.51%
7.41%
38.79%
4.29%

TCM FAQs

TCM share price is ₹65 As on 18 November, 2025 | 00:53

The Market Cap of TCM is ₹49.3 Cr As on 18 November, 2025 | 00:53

The P/E ratio of TCM is 347 As on 18 November, 2025 | 00:53

The PB ratio of TCM is 1.8 As on 18 November, 2025 | 00:53

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23